Expert Opinion on Pharmacotherapy  on Taylor & 
   Francis Online 


   An overview of letermovir: a cytomegalovirus prophylactic option 
   Giuseppe Gerna, Daniele Lilleri & Fausto Baldanti 
   Pages: 1-10 
   DOI: 10.1080/14656566.2019.1637418 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160842&key=Hhip2uvDCBlBUfSkAkh5gVhM%2BW2kYmm26M88FtcAVUc%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F14656566.2019.1637418%3Fai%3D1vr12%26ui%3D843fx%26af%3DT 

   Important considerations when choosing pharmacotherapy for Graves’ 
   disease in children 
   Aleksandra Król, Jolanta Krajewska & Barbara Jarzab 
   Pages: 1-3 
   DOI: 10.1080/14656566.2019.1638365 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160842&key=Hhip2uvDCBlBUfSkAkh5gVhM%2BW2kYmm26M88FtcAVUc%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F14656566.2019.1638365%3Fai%3D1vr12%26ui%3D843fx%26af%3DT 

   Pharmacotherapeutic management of psoriasis in adolescents and 
   children 
   S. D’Adamio, D. Silvaggio, A. Massaro, P. Lombardo, L. Bianchi, M. 
   Talamonti & M. Galluzzo 
   Pages: 1-9 
   DOI: 10.1080/14656566.2019.1636032 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160842&key=Hhip2uvDCBlBUfSkAkh5gVhM%2BW2kYmm26M88FtcAVUc%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F14656566.2019.1636032%3Fai%3D1vr12%26ui%3D843fx%26af%3DT 

   Treatment of hypertension in the elderly in 2017/2018 - what’s new? 
   Michel Burnier 
   Pages: 1-9 
   DOI: 10.1080/14656566.2019.1638911 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160842&key=Hhip2uvDCBlBUfSkAkh5gVhM%2BW2kYmm26M88FtcAVUc%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F14656566.2019.1638911%3Fai%3D1vr12%26ui%3D843fx%26af%3DT 

   Challenges and strategies for successful clinical development of 
   immune checkpoint inhibitors in glioblastoma 
   Nazanin Majd & John de Groot 
   Pages: 1-16 
   DOI: 10.1080/14656566.2019.1621840 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160842&key=Hhip2uvDCBlBUfSkAkh5gVhM%2BW2kYmm26M88FtcAVUc%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F14656566.2019.1621840%3Fai%3D1vr12%26ui%3D843fx%26af%3DT 

   Recent advances in the pharmacotherapy of epilepsy: brivaracetam and 
   perampanel as broad-spectrum antiseizure drugs for the treatment of 
   epilepsies and status epilepticus 
   Laurent Maximilian Willems, Sebastian Bauer, Felix Rosenow & Adam 
   Strzelczyk 
   Pages: 1-11 
   DOI: 10.1080/14656566.2019.1637420 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160842&key=Hhip2uvDCBlBUfSkAkh5gVhM%2BW2kYmm26M88FtcAVUc%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F14656566.2019.1637420%3Fai%3D1vr12%26ui%3D843fx%26af%3DT